Skip to main content

and
  1. Article

    Open Access

    Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition

    Pancreatic cancer, one of the deadliest human malignancies, has a dismal 5-year survival rate of 9%. KRAS is the most commonly mutated gene in pancreatic cancer, but clinical agents that directly target mutant KR...

    Arthur Brannon III, Donovan Drouillard, Nina Steele, Shadae Schoettle in Scientific Reports (2020)